These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 6321681
1. Clinical trial of the effect of S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR-2721) (NSC 296961) on the toxicity of cyclophosphamide. Woolley PV, Ayoob MJ, Smith FP, Dritschilo A. J Clin Oncol; 1983 Mar; 1(3):198-203. PubMed ID: 6321681 [Abstract] [Full Text] [Related]
2. WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial. Glover D, Glick JH, Weiler C, Hurowitz S, Kligerman MM. J Clin Oncol; 1986 Apr; 4(4):584-8. PubMed ID: 3007686 [Abstract] [Full Text] [Related]
3. Phase I trials of WR2721 in combination with radiation therapy and with the alkylating agents cyclophosphamide and cis-platinum. Kligerman MM, Blumberg AL, Glick JH, Nelson DF, Glover D, Yuhas JM, Amols HI, Goodman RL. Cancer Clin Trials; 1981 Apr; 4(4):469-74. PubMed ID: 6274534 [Abstract] [Full Text] [Related]
4. Phase I controlled trials of WR-2721 and cyclophosphamide. Glick JH, Glover D, Weiler C, Norfleet L, Yuhas J, Kligerman MM. Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1777-80. PubMed ID: 6090370 [Abstract] [Full Text] [Related]
5. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Milas L, Hunter N, Stephens LC, Peters LJ. Cancer Res; 1984 Dec; 44(12 Pt 1):5567-9. PubMed ID: 6093999 [Abstract] [Full Text] [Related]
18. Radioprotection of pronormoblasts and normoblasts by WR-2721. Naruka K, Bhartiya HC. Strahlenther Onkol; 1990 Aug; 166(8):542-4. PubMed ID: 2168582 [Abstract] [Full Text] [Related]
19. Promotion of cystine uptake, increase of glutathione biosynthesis, and modulation of glutathione status by S-2-(3-aminopropylamino)ethyl phosphorothioic acid (WR-2721) in Chinese hamster cells. Issels RD, Nagele A. Cancer Res; 1989 Apr 15; 49(8):2082-6. PubMed ID: 2539252 [Abstract] [Full Text] [Related]
20. Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy. Capizzi RL, Scheffler BJ, Schein PS. Cancer; 1993 Dec 01; 72(11 Suppl):3495-501. PubMed ID: 8242582 [Abstract] [Full Text] [Related] Page: [Next] [New Search]